Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
NVP-LAQ824 treatment of NDHF cells causes the expected G1-S growth arrest in addition to a significant reduction of cells in S-phase and accumulation of cells at the G2-M checkpoint
Wilkinson-Berka JL
3 h in the four species
Formula: C21H20N4O3
PubMed PMID: 29193663
(±)Eriodictyol - an ADAM17 inhibitor. CAS# 4049-38-1 064 NVP-LAQ824 treatment of NDHF cells()Eriodictyol, an ADAM17 inhibitor, CAS No. 4049 38 1, is a potent TRPV1 antagonist. () Eriodictyol inhibits capsaicin induced Ca2+ influx in synaptosomes and exhibits antinociceptive activity in animal models without affecting body temperature. () Eriodictyol is also an antioxidant that protects against H2O2 induced neurotoxicity in vitro by activation of Nrf2 ARE signaling. Modeling studies predict binding to ACE2 preventing its interaction with
US$ 69.99
US$ 34.89
US$ 14.00